| scholarly article | Q13442814 |
| P2093 | author name string | Roth JA | |
| Ji L | |||
| Fang B | |||
| Bouvet M | |||
| P2860 | cites work | Specific DNA binding of GAL4, a positive regulatory protein of yeast | Q27939693 |
| GAL4-VP16 is an unusually potent transcriptional activator | Q29616453 | ||
| A regulatory system for use in gene transfer | Q35686843 | ||
| The mouse Pgk-1 gene promoter contains an upstream activator sequence | Q35788889 | ||
| A selective transcriptional induction system for mammalian cells based on Gal4-estrogen receptor fusion proteins | Q36122736 | ||
| Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements. | Q37381925 | ||
| Properties of initiator-associated transcription mediated by GAL4-VP16. | Q40656959 | ||
| Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography | Q41275967 | ||
| GAL4 activates transcription in Drosophila. | Q52459487 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4972-4975 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Evaluation of GAL4/TATA in vivo. Induction of transgene expression by adenovirally mediated gene codelivery | |
| P478 | volume | 273 |
| Q45865366 | A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. |
| Q40793451 | A role for mitochondrial Bak in apoptotic response to anticancer drugs |
| Q36474111 | Anti-liver cancer activity of TNF-related apoptosis-inducing ligand gene and its bystander effects |
| Q45855281 | Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft |
| Q43902939 | Differential involvement of Bax and Bak in TRAIL-mediated apoptosis of leukemic T cells |
| Q33391325 | Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound |
| Q35100683 | Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus |
| Q40628018 | Enhancing adenovirus‐mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisone |
| Q40431186 | Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells |
| Q40244313 | GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain |
| Q36909702 | JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase |
| Q40705843 | Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line. |
| Q35596426 | Molecular therapy for peritoneal dissemination of xenotransplanted human MKN-45 gastric cancer cells with adenovirus mediated Bax gene transfer |
| Q38327006 | Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. |
| Q33273469 | Novel system uses probasin-based promoter, transcriptional silencers and amplification loop to induce high-level prostate expression |
| Q52731749 | Overcoming resistance to anti-PD immunotherapy in a syngeneic mouse lung cancer model using locoregional virotherapy. |
| Q35001648 | Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma |
| Q34313135 | Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer |
| Q36663422 | Redirecting adaptive immunity against foreign antigens to tumors for cancer therapy |
| Q36376406 | Resistance to granzyme B-mediated cytochrome c release in Bak-deficient cells |
| Q45108559 | Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter |
| Q35768756 | Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter |
| Q40055885 | Telomerase transcriptional targeting of inducible Bax/TRAIL gene therapy improves gemcitabine treatment of pancreatic cancer |
| Q38721966 | Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer |
| Q36649490 | Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. |
| Q45865848 | Treatment of patient tumor-derived colon cancer xenografts by a TRAIL gene-armed oncolytic adenovirus |
| Q36663418 | Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus |
| Q40651834 | Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29 |
| Q34595455 | Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma |
| Q33952065 | Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters |
Search more.